What exactly is in The Alpha Blend?

The precise composition is proprietary to the vendor, but it follows the standard GH secretagogue model of pairing a GHRH analog with one or more ghrelin-receptor agonists; check the specific product listing for the exact peptides and ratios.

How does a proprietary blend differ from a named blend?

Named blends specify their exact peptides and often their amounts, whereas a proprietary blend like this may disclose only the general category, so research handling and dosing should follow the vendor's stated component details.

← All peptides

Growth Hormone Secretagogues

Research Chemical

The Alpha Blend

Also known as: The Alpha Blend

A vendor-formulated multi-peptide research blend marketed around growth hormone secretagogue activity. It typically combines a GHRH analog with one or more ghrelin-receptor agonists for synergistic GH release.

Mechanism of Action

The Alpha Blend is built around the established growth hormone secretagogue model in which a GHRH-receptor analog (such as CJC-1295 No DAC or a sermorelin-type peptide) amplifies pituitary GH pulse amplitude, while a selective ghrelin (GHS-R1a) receptor agonist such as Ipamorelin evokes an additional GH pulse. Because these components act on distinct receptor systems, their co-administration produces a synergistic, greater-than-additive release of pulsatile growth hormone and downstream IGF-1. The exact peptide ratios are proprietary to the vendor, but the pharmacology follows the standard dual-pathway GH secretagogue mechanism.

Half-life: Mixed and component-dependent: generally ~30 minutes to ~2 hours across the constituent secretagogues
Administration Routes: subcutaneous
Research Status: Research Chemical